3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
12
Breast Neoplasms
7
Neoplasm Metastasis
5
Lymphoma
5
Multiple Myeloma
4
Leukemia
4
Hematologic Neoplasms
4
Colorectal Neoplasms
4
Prostatic Neoplasms
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Depression
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Ovarian Neoplasms
2
Motor Activity
2
Malignant Female Reproductive System Neoplasm
2
Glioblastoma
2
Fatigue
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
Caregiver Burden
2
Anxiety Disorders
2
Advanced Malignant Solid Neoplasm
2
Thyroid Neoplasms
1
Stroke
1
Stress Disorders, Post-Traumatic
1
Squamous Cell Carcinoma of Head and Neck
1
Sleep Initiation and Maintenance Disorders
1
Signs and Symptoms
1
Interventions
pembrolizumab
69
Nivolumab
67
cabozantinib
45
Ipilimumab
36
Specimen Handling
32
Magnetic Resonance Spectroscopy
32
lenvatinib
26
Axitinib
25
belzutifan
21
Sunitinib
17
Biopsy
15
Radiosurgery
14
CTLA-4 Antigen
13
atezolizumab
12
Everolimus
10
pazopanib
8
fludarabine
8
avelumab
8
Bevacizumab
8
toripalimab
7
cemiplimab
7
Nephrectomy
7
Immunoglobulin G
7
Cyclophosphamide
7
aldesleukin
6
Standard of Care
6
Radiotherapy
6
Blood Specimen Collection
6
spartalizumab
5
palbociclib
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
Palliative Care
×
1 year
×
Clear all
No trials found.